Keybank National Association OH Sells 15,731 Shares of STERIS plc (NYSE:STE)

Keybank National Association OH decreased its holdings in STERIS plc (NYSE:STE) by 33.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 30,704 shares of the medical equipment provider’s stock after selling 15,731 shares during the quarter. Keybank National Association OH’s holdings in STERIS were worth $6,312,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Ashton Thomas Securities LLC bought a new position in STERIS in the 3rd quarter valued at $25,000. Human Investing LLC bought a new stake in shares of STERIS during the fourth quarter worth $31,000. Anfield Capital Management LLC raised its position in shares of STERIS by 100.0% during the fourth quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 91 shares during the last quarter. Central Pacific Bank Trust Division raised its position in shares of STERIS by 65.5% during the fourth quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 76 shares during the last quarter. Finally, Manchester Capital Management LLC raised its position in shares of STERIS by 182.7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock worth $44,000 after acquiring an additional 137 shares during the last quarter. Institutional investors own 94.69% of the company’s stock.

STERIS Stock Up 0.8 %

Shares of STERIS stock opened at $227.51 on Thursday. The company has a quick ratio of 1.40, a current ratio of 2.13 and a debt-to-equity ratio of 0.32. STERIS plc has a 12 month low of $197.82 and a 12 month high of $248.24. The business has a fifty day simple moving average of $215.99 and a 200 day simple moving average of $222.79. The stock has a market cap of $22.35 billion, a PE ratio of 48.30 and a beta of 0.84.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing analysts’ consensus estimates of $2.33 by ($0.01). STERIS had a return on equity of 13.91% and a net margin of 8.66%. Research analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 21st. Shareholders of record on Thursday, February 20th will be paid a $0.57 dividend. The ex-dividend date is Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.00%. STERIS’s payout ratio is 48.41%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the company. Stephens restated an “overweight” rating and set a $240.00 target price on shares of STERIS in a research report on Thursday, February 6th. JMP Securities restated a “market outperform” rating and set a $265.00 target price on shares of STERIS in a research report on Thursday, February 6th. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research report on Friday, November 8th. Finally, Piper Sandler boosted their target price on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research report on Monday, February 3rd. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, STERIS has an average rating of “Moderate Buy” and an average price target of $258.75.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.